RA CAPITAL MANAGEMENT LLC 13D and 13G filings for Larimar Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-26 4:17 pm Purchase |
2024-02-16 | 13G | Larimar Therapeutics, Inc. LRMR |
RA CAPITAL MANAGEMENT LLC | 6,045,351 9.500% |
6,045,351 (New Position) |
Filing |
| 2022-11-14 4:43 pm Sale |
2022-11-14 | 13G | Larimar Therapeutics, Inc. LRMR |
RA CAPITAL MANAGEMENT LLC | 0 0.000% |
-1,334,610 (Position Closed) |
Filing |
| 2022-02-14 4:11 pm Sale |
2021-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
RA CAPITAL MANAGEMENT LLC | 1,334,610 7.500% |
-180,541 (-11.92%) |
Filing |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
RA CAPITAL MANAGEMENT LLC | 1,515,151 9.900% |
1,515,151 (New Position) |
Filing |